Skip to main content
. 2016 Jan 29;46(4):291–298. doi: 10.1093/jjco/hyv207

Table 1.

EGFR inhibitor-associated dermatological toxicity

Organ site Clinical manifestation
Skin Acneiform rash (papulopustular rash)
Xerosis
Erythema
Photosensitivity
Fissures and crack
Hyperpigmentation
Telangiectasia
Pruritus
Nail Paronychia
Onyxis
Hair Trichomegaly in eyelash
Hypertrichosis in eyelash, eyebrow and mustache
Alopecia in scalp hair
Eye Conjunctivitis
Blepharitis
Xerotic
Keratitis
Lacrimation

EGFR, epidermal growth factor receptor.